statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 acciones de salud en movimiento en la subasta de cierre del 01/04/2024

Acciones al alza
OpGen (NASDAQ:OPGN) experimentaron un repunte del 19,36% para establecerse en los 0,71 d lares durante la sesi n del after-market del lunes.
Matinas BioPharma Hldgs (AMEX:MTNB) se...

OpGen Inc Secures $3M Investment, Enhances Corporate Structure

OpGen Inc (OPGN) just unveiled an update. OpGen, Inc. has struck a deal with investor David E. Lazar, who will purchase 3 million shares of Series...

12 titres de soins de sant  en mouvement lors de la pr -ouverture le 26/03/2024

Gagnants
L'action OpGen (NASDAQ:OPGN) a grimp mardi de 100,82% 0,95 dollars lors de la session pre-market.
L'action Stoke Therapeutics (NASDAQ:STOK) a augment de 75,38% 11,40 dollars. D'apr s...

12 titoli sanitari in movimento, pre-market del 26/03/2024

Titoli in rialzo
Il titolo OpGen (NASDAQ:OPGN) ha osservato un incremento del 100,69% a 0,95 dollari durante la sessione pre-market di marted .
Le azioni di Stoke Therapeutics (NASDAQ:STOK) hanno...

12 acciones de salud en movimiento durante la preapertura del 26/03/2024

Acciones al alza
OpGen (NASDAQ:OPGN) ganaron un 103,22% para establecerse en los 0,97 d lares durante la sesi n del pre-market del martes.
Stoke Therapeutics (NASDAQ:STOK) crecieron un 77,84% para...

OpGen stock jumps after David Lazar invests $3M, takes over as CEO

OpGen stock jumps after David Lazar invests $3M, takes over as CEO...

OpGen CEO Oliver Schacht resigns, David Lazar to succeed following investment

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

OpGen Announces Acquisition of Preferred Stock by David Lazar

David Lazar invests $3 million in Preferred StockNew OpGen Board of Directors appointedDavid Lazar will take over as CEO of OpGenOpGen settles outstanding liabilities with EIB ROCKVILLE, Md., March...

OpGen Inc Granted Extension to Meet Nasdaq Compliance

OpGen Inc (OPGN) has released an update. OpGen, Inc., facing the threat of being delisted from Nasdaq due to not meeting the minimum bid price requ...

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.

Volume	4,996.00
52-Wk High	$38.40
52-Wk Low	$1.65

OPGN Opgen Inc

About

Feed

News

Earnings

Fundamentals